CIDARA THERAPEUTICS INC (CDTX)
US1717572069 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 35.78M | 32.70M | 59.70M | 35.90M | 50.30M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 16.25M | 5.80M | 5.40M | 11.20M | 5.50M | |||
| Inventories | 6.10M | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 2.73M | 6.50M | 6.70M | 10.10M | 10.00M | |||
| Total Current Assets | 60.85M | 45.10M | 71.70M | 57.20M | 65.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 5.13M | 1.40M | 2.50M | 1.20M | 2.10M | |||
| Other Non-Current Assets | 1.05M | 1.10M | 1.10M | 2.00M | 1.10M | |||
| Total Non-Current Assets | 6.17M | 2.50M | 3.60M | 3.20M | 3.20M | |||
| TOTAL ASSETS | 67.03M | 47.60M | 75.30M | 60.40M | 69.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 218.00K | 0.00 | 2.60M | 7.00M | 10.00M | |||
| Accrued Expenses | 38.33M | 13.90M | 16.20M | 13.10M | 8.50M | |||
| Accounts Payable | 3.77M | 1.40M | 1.30M | 4.60M | 1.90M | |||
| Other Current Liabilities | 25.09M | 14.60M | 13.90M | 13.90M | 9.80M | |||
| Total Current Liabilities | 67.42M | 30.00M | 34.00M | 38.60M | 30.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 575.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 7.25M | 20.50M | 19.70M | 11.10M | 900.00K | |||
| Total Non-Current Liabilities | 7.82M | 20.50M | 19.80M | 11.10M | 900.00K | |||
| TOTAL LIABILITIES | 75.24M | 50.50M | 53.80M | 49.70M | 31.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -441.43M | -407.00M | -377.20M | -334.70M | -259.80M | |||
| Additional Paid In Capital | 433.21M | 404.10M | 398.70M | 345.40M | 297.70M | |||
| Common Shares | 9.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 90.60M | 72.50M | 67.90M | 44.90M | 33.80M | |||
| Tangible Book Value per Share | -0.09 | -0.04 | 0.32 | 0.24 | 1.12 | |||
| Total Shareholders' Equity | -8.21M | -2.90M | 21.60M | 10.70M | 37.80M | |||
| TOTAL LIABILITIES AND EQUITY | 67.03M | 47.60M | 75.30M | 60.40M | 69.00M | |||
| Statistics | ||||||||
| Debt/Equity | -0.07 | N/A | N/A | N/A | N/A | |||
| Current Ratio | 0.90 | 1.50 | 2.11 | 1.48 | 2.18 | |||
| Return On Assets (ROA) | -34.21% | -62.61% | -56.40% | -123.96% | -59.55% | |||
| Return On Equity (ROE) | N/A | N/A | -196.62% | -699.72% | -108.70% | |||
All data in USD